{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:37:24Z","timestamp":1775590644893,"version":"3.50.1"},"reference-count":90,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Genitourinary malignancies are characterized by marked heterogeneity in tumor biology, clinical behavior and therapeutic outcomes. Despite significant progress in surgical and systemic treatments, resistance to therapy remains a major challenge, highlighting the need to identify additional host-related determinants of disease progression and treatment response. Within this framework, converging experimental and clinical evidence indicates that host-associated microbial ecosystems may influence key biological processes involved in tumor\u2013host interactions, including immune modulation, metabolic regulation and inflammatory pathways. Altered microbial profiles have been associated with oncogenic signaling, changes in the tumor microenvironment and differences in clinical benefit from systemic therapies, particularly immunotherapeutic approaches. This review brings together preclinical, translational and clinical evidence on the involvement of microbiota in renal, prostate, bladder and testicular cancers, with attention to biological mechanisms and clinically meaningful correlations with disease characteristics. While current data are largely observational, early interventional studies suggest that modulation of microbial ecosystems may influence therapeutic activity in selected clinical settings. Collectively, these findings support microbiota as a relevant component of genitourinary cancer biology with potential implications for precision medicine approaches.<\/jats:p>","DOI":"10.3390\/cancers18030497","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:00:58Z","timestamp":1770109258000},"page":"497","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding Microbiota in Genitourinary Oncology: Biological Mechanisms and Clinical Implications\u2014A Narrative Review"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7422-0119","authenticated-orcid":false,"given":"Irene","family":"Caramella","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Abeni","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cherri","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Ogliosi","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4958-3780","authenticated-orcid":false,"given":"Tonino","family":"Morena","sequence":"additional","affiliation":[{"name":"Department of Urology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Galvagni","sequence":"additional","affiliation":[{"name":"Department of Urology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Meriggi","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zaniboni","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Fondazione Poliambulanza, 25124 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3892\/ol.2025.15273","article-title":"Tumor-associated microbiota: Multi-cancer landscape, mechanistic insights and clinical translation (Review)","volume":"30","author":"Yang","year":"2025","journal-title":"Oncol. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486, 207\u2013214.","DOI":"10.1038\/nature11234"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12094-021-02690-x","article-title":"Microbiota and cancer: Current understanding and mechanistic implications","volume":"24","author":"Khan","year":"2022","journal-title":"Clin. Transl. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100829","DOI":"10.1016\/j.neo.2022.100829","article-title":"Microbiota-driven mechanisms at different stages of cancer development","volume":"32","author":"Ivleva","year":"2022","journal-title":"Neoplasia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","article-title":"The gut microbiome and cancer: From tumorigenesis to therapy","volume":"7","author":"Nobels","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113945","DOI":"10.1016\/j.isci.2025.113945","article-title":"Understanding microbiota-driven oncogenesis: The role of metabolites in tumorigenesis","volume":"28","author":"Ullah","year":"2025","journal-title":"iScience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101944","DOI":"10.1016\/j.bpg.2024.101944","article-title":"The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy","volume":"72","author":"Dean","year":"2024","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e184321","DOI":"10.1172\/JCI184321","article-title":"The gut microbiome and cancer response to immune checkpoint inhibitors","volume":"135","author":"Gazzaniga","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euf.2019.04.004","article-title":"An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma","volume":"6","author":"Dudani","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e100041","DOI":"10.1200\/EDBK_100041","article-title":"Clinical Applications of the Gut Microbiome in Genitourinary Cancers","volume":"44","author":"Nguyen","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.urolonc.2024.07.003","article-title":"The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma","volume":"43","author":"Zugman","year":"2025","journal-title":"Urol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13402-023-00876-9","article-title":"The microbiota and renal cell carcinoma","volume":"47","author":"Wu","year":"2024","journal-title":"Cell. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dai, G., Chen, X., and He, Y. (2021). The Gut Microbiota Activates AhR Through the Tryptophan Metabolite Kyn to Mediate Renal Cell Carcinoma Metastasis. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.712327"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4111\/icu.20220124","article-title":"Urinary microbiome profile in men with genitourinary malignancies","volume":"63","author":"Ahn","year":"2022","journal-title":"Investig. Clin. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/aje\/kwh014","article-title":"History of urinary tract infection and risk of renal cell carcinoma","volume":"159","author":"Parker","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","article-title":"The Microbiome and Genitourinary Cancer: A Collaborative Review","volume":"75","author":"Markowski","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ucl.2004.01.004","article-title":"Risk factors for adult renal cell carcinoma","volume":"31","author":"Dhote","year":"2004","journal-title":"Urol. Clin. N. Am."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.semcancer.2020.06.011","article-title":"The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC)","volume":"70","author":"Gupta","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrurol.2014.361","article-title":"The microbiome of the urinary tract--a role beyond infection","volume":"12","author":"Whiteside","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9068068","DOI":"10.1155\/2020\/9068068","article-title":"Microbiome within Primary Tumor Tissue from Renal Cell Carcinoma May Be Associated with PD-L1 Expression of the Venous Tumor Thrombus","volume":"2020","author":"Liss","year":"2020","journal-title":"Adv. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00432-020-03462-w","article-title":"Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing","volume":"147","author":"Wang","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wu, J., Zhang, P., Mei, W., and Zeng, C. (2024). Intratumoral microbiota: Implications for cancer onset, progression, and therapy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1301506"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00345-024-05403-5","article-title":"Research progress on intratumoral microorganisms in renal cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"World J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdy103","article-title":"Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer","volume":"29","author":"Derosa","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.euo.2019.09.001","article-title":"Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma","volume":"3","author":"Lalani","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Petrelli, F., Iaculli, A., Signorelli, D., Ghidini, A., Dottorini, L., Perego, G., Ghidini, M., Zaniboni, A., Gori, S., and Inno, A. (2020). Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis. J. Clin. Med., 9.","DOI":"10.20944\/preprints202003.0425.v1"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lopes, S., Pabst, L., Dory, A., Klotz, M., Gourieux, B., Michel, B., and Mascaux, C. (2023). Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1070076"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00262-020-02786-3","article-title":"Antibiotics and steroids, the double enemies of anticancer immunotherapy: A review of the literature","volume":"70","author":"Meriggi","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101478","DOI":"10.1016\/j.xcrm.2024.101478","article-title":"Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy","volume":"5","author":"Kang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.euf.2024.12.006","article-title":"Clinical Applications of Microbiome in Renal Cell Carcinoma","volume":"10","author":"Elyas","year":"2024","journal-title":"Eur. Urol. Focus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","article-title":"Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients","volume":"78","author":"Derosa","year":"2020","journal-title":"Eur. Urol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yang, J.W., Wan, S., Li, K.P., Chen, S.Y., and Yang, L. (2023). Gut and urinary microbiota: The causes and potential treatment measures of renal cell carcinoma. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1188520"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2268982","DOI":"10.1080\/21645515.2023.2268982","article-title":"Gut microbiota and immunotherapy of renal cell carcinoma","volume":"19","author":"Porcari","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_39","first-page":"420","article-title":"Fecal microbiota transplantation: Past, present and future perspectives","volume":"63","author":"Ianiro","year":"2017","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-020-18127-y","article-title":"Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma","volume":"11","author":"Ianiro","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Huang, H., Liu, Y., Wen, Z., Chen, C., Wang, C., Li, H., and Yang, X. (2024). Gut microbiota in patients with prostate cancer: A systematic review and meta-analysis. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-12018-x"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15698\/mic2022.12.787","article-title":"Effects of the intestinal microbiota on prostate cancer treatment by androgen deprivation therapy","volume":"9","author":"Terrisse","year":"2022","journal-title":"Microb. Cell"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zha, C., Peng, Z., Huang, K., Tang, K., Wang, Q., Zhu, L., Che, B., Li, W., Xu, S., and Huang, T. (2023). Potential role of gut microbiota in prostate cancer: Immunity, metabolites, pathways of action?. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1196217"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Fujita, K., Matsushita, M., De Velasco, M.A., Hatano, K., Minami, T., Nonomura, N., and Uemura, H. (2023). The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome. Cancers, 15.","DOI":"10.3390\/cancers15051375"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12672-024-00925-1","article-title":"Causal relationship between gut microbiota and prostate cancer contributes to the gut-prostate axis: Insights from a Mendelian randomization study","volume":"15","author":"Wang","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Magashi Ali, M.A., and Abdulkadir, S.A. (2025). Modulating Prostate Cancer Therapy Through the Gut Microbiome: A Comprehensive Review. Cancers, 17.","DOI":"10.3390\/cancers17233842"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e00889","DOI":"10.1128\/mBio.00889-14","article-title":"Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data","volume":"5","author":"Vital","year":"2014","journal-title":"mBio"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/intimm\/dxaa079","article-title":"Gut microbiota and systemic immunity in health and disease","volume":"33","author":"Lo","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jaut.2018.05.008","article-title":"Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex","volume":"92","author":"Rizzetto","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00345-016-1914-3","article-title":"Prostate cancer progression and mortality: A review of diet and lifestyle factors","volume":"35","author":"Peisch","year":"2017","journal-title":"World J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.juro.2017.08.001","article-title":"Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer","volume":"199","author":"Shrestha","year":"2018","journal-title":"J. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","article-title":"Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies","volume":"21","author":"Sfanos","year":"2018","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","article-title":"The Microbiome of the Prostate Tumor Microenvironment","volume":"72","author":"Cavarretta","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijmm.2010.08.014","article-title":"Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells","volume":"301","author":"Mak","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/carcin\/bgz008","article-title":"Microbiome signatures in prostate cancer","volume":"40","author":"Banerjee","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e0149721","DOI":"10.1128\/spectrum.01497-21","article-title":"Cutibacterium acnes Induces the Expression of Immunosuppressive Genes in Macrophages and is Associated with an Increase of Regulatory T-Cells in Prostate Cancer","volume":"9","author":"Davidsson","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: The evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41391-023-00723-w","article-title":"Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer","volume":"27","author":"Wang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Gherasim, R.D., Chibelean, C., Porav-Hodade, D., Todea-Moga, C., T\u0103taru, S.O., Reman, T.L., Vida, A.O., Ghirca, M.V., Ferro, M., and Martha, O.K.I. (2025). Microbiome Shifts in Bladder Cancer: A Narrative Review of Urobiome Composition, Progression, and Therapeutic Impact. Medicina, 61.","DOI":"10.3390\/medicina61081401"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.urolonc.2024.07.004","article-title":"Understanding the microbiome as a mediator of bladder cancer progression and therapeutic response","volume":"43","author":"Golshani","year":"2025","journal-title":"Urol. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41388-017-0099-6","article-title":"A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer","volume":"37","author":"Fantini","year":"2018","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wu, P., Zhang, G., Zhao, J., Chen, J., Chen, Y., Huang, W., Zhong, J., and Zeng, J. (2018). Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00429"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: An exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota\u2014A potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: Examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.urolonc.2020.04.014","article-title":"Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study","volume":"38","author":"Chipollini","year":"2020","journal-title":"Urol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"22198","DOI":"10.1038\/s41598-024-72918-7","article-title":"Intratumoral microbiota as a novel prognostic indicator in bladder cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Heidar, N.A., Bhat, T.A., Shabir, U., and Hussein, A.A. (2023). The Urinary Microbiome and Bladder Cancer. Life, 13.","DOI":"10.3390\/life13030812"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12943-025-02403-w","article-title":"The tumor microbiome in cancer progression: Mechanisms and therapeutic potential","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Boban, T., Mili\u0107 Roje, B., Knezovi\u0107, D., Jeron\u010di\u0107, A., \u0160o\u0161i\u0107, H., \u0160itum, M., and Terzi\u0107, J. (2025). Urinary microbiota changes among NMIBC patients during BCG therapy: Comparing BCG responders and non-responders. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1479795"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.23736\/S2724-6051.25.06431-6","article-title":"Exploring the influence of the bladder microbiome on BCG immunotherapy outcomes for high-risk non muscle invasive bladder cancer","volume":"77","author":"Tulone","year":"2025","journal-title":"Minerva Urol. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","article-title":"Treatment of testicular cancer: A new and improved model","volume":"8","author":"Einhorn","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: Gut microbiota: The neglected endocrine organ","volume":"28","author":"Clarke","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Santacroce, L., Imbimbo, C., Ballini, A., Crocetto, F., Scacco, S., Cantore, S., Di Zazzo, E., Colella, M., and Jirillo, E. (2022). Testicular Immunity and Its Connection with the Microbiota. Physiological and Clinical Implications in the Light of Personalized Medicine. J. Pers. Med., 12.","DOI":"10.3390\/jpm12081335"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Liu, S., Cao, R., Liu, L., Lv, Y., Qi, X., Yuan, Z., Fan, X., Yu, C., and Guan, Q. (2022). Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.836485"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/andr.12886","article-title":"The semen microbiome and its impact on sperm function and male fertility: A systematic review and meta-analysis","volume":"9","author":"Farahani","year":"2021","journal-title":"Andrology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/annonc\/mdx680","article-title":"Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: A Hoosier Cancer Research Network Study GU14-206","volume":"29","author":"Adra","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Cort\u00e9s, M., Olate, P., Rodriguez, R., Diaz, R., Mart\u00ednez, A., Hern\u00e1ndez, G., Sepulveda, N., Paz, E.A., and Qui\u00f1ones, J. (2025). Human Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation. Microorganisms, 13.","DOI":"10.3390\/microorganisms13092147"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Petrelli, F., Ghidini, A., Dottorini, L., Ghidini, M., Zaniboni, A., and Tomasello, G. (2025). Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review. Medicina, 61.","DOI":"10.3390\/medicina61091595"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Winslow, T.B., Gupta, S., Vaddaraju, V.S., Guercio, B.J., and Sahasrabudhe, D.M. (2025). The Microbiome and Genitourinary Cancers: A New Frontier. Cancers, 17.","DOI":"10.3390\/cancers17223606"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"271ps1","DOI":"10.1126\/scitranslmed.3010473","article-title":"Cancer and the gut microbiota: An unexpected link","volume":"7","author":"Zitvogel","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Filardo, S., Di Pietro, M., and Sessa, R. (2024). Current progresses and challenges for microbiome research in human health: A perspective. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1377012"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/497\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:10:49Z","timestamp":1770109849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/3\/497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cancers18030497"],"URL":"https:\/\/doi.org\/10.3390\/cancers18030497","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}